Repeal & Replace Watch
Where There’s Willingness, There’s A Way For Congress And Trump To Fix Health Law
After the collapse of the Republican replacement plan, there may be a way to find consensus and repair the law.
Health Industry
2,641-2,660 of 4,027 results
-
-
Trump’s Effort To Lure Consumers To Exchanges Could Bring Skimpier Plans
The changes proposed by the administration for the health law marketplaces in 2018 could increase customersā out-of-pocket costs and reduce the amount they receive in premium tax credits.
-
Also Made In Mexico: Lifesaving Devices
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
By Sarah Varney -
‘The Trump Of Georgiaā Goes To Washington
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
-
California Doctors Again Press For More Money To Treat Poor Patients
They want the stateās new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
-
Senators Demand Answers About Possible Probe Of HHS Secretary Price
Democratic senators want the Justice Department to reveal what it knows about ProPublicaās recent report that HHS Secretary Tom Priceās stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
By Rachel Bluth and Emily Kopp -
March Madness Vasectomies Encourage Guys To Take One For The Team
Some urologists use March Madness as an opportunity to market vasectomy services, offering men the excuse to sit on the sofa for three days to watch college basketball while they recover.
-
Justice Department Joins Lawsuit Alleging Massive Medicare Fraud By UnitedHealth
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
By Fred Schulte -
Repeal & Replace Watch
Insurers May Notch Bigger Profits From Fewer Customers In āTrumpcareā
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what itās seeing.
-
Repeal & Replace Watch
Popular Guarantee For Young Adultsā Coverage May Be Health Lawās Achilles’ Heel
Republicans and Democrats donāt agree on much these days, but both parties want to keep the health lawās provision to allow adults to stay on their parentsā plan until age 26. But that could be hurting the marketplaceās insurance pools.
-
GAO To Launch Investigation Of FDAās Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
-
Repeal & Replace Watch
House Republicans Recycle Controversial 2003 Bill To Boost Small-Business Insurance
The legislation, passed by the House, would allow nationwide āassociation health plans.ā But consumer advocates have raised serious concerns about such options in the past.
-
Repeal & Replace Watch
In Deep-Red Western N.C., Revered Congressman Leads Charge Against GOP Bill
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOPās plan for repealing and replacing Obamacare.
-
Repeal & Replace Watch
GOP Bill’s Unheralded Changes In Rules Could Undermine Health Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
By Emily Bazar -
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
By Bruce Horovitz and Julie Appleby -
Travel Ban Adds Stress To ‘Match Week’ For Some Doctors
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
-
Repeal & Replace Watch
Report: Fired U.S. Attorney Was Probing Tom Priceās Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
By Emily Kopp and Rachel Bluth -
Cholesterol Drug Prevents Heart Attacks ā But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
By Liz Szabo -
$89,000 Orphan Drug Gets A New Owner ā And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo